🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,911 results for “Pharma” Clear

  1. CINRYZE 500

    Takeda Pharmaceuticals International AG

    Hereditary Angioedema (HAE)

    phase 3 mab completed

    1 trial

  2. CINRYZE 500 U

    Takeda Pharmaceuticals International AG

    Hereditary Angioedema (HAE)

    phase 3 small molecule completed

    1 trial

  3. CISPLATIN

    Cancer Prevention Pharma (Ireland) Limited

    Ovarian epithelial cancer : intraperitoneal resectable relapse

    phase 3 small molecule active

    1 trial

  4. COLCHICINE OPOCALCIUM 1 mg, comprimé sécable

    Pari Pharma GmbH

    Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis, Myocardial Infarction, Coronary Syndrome, Cerebral Infarction

    phase 3 small molecule active

    1 trial

  5. CORTANCYL 20 mg, comprimé sécable, Placebo of CORTANCYL 20 mg

    Pari Pharma GmbH

    Adults patients with isolated acute urticaria presenting to the emergency department

    phase 3 small molecule active

    1 trial

  6. CORTANCYL 20 mg, comprimé sécable, placebo of Cortancyl 20 mg, NaCl 0,9% as placebo of kineret, Kineret 100 mg/0.67 ml solution for injection in pre-filled syringe.

    Pari Pharma GmbH

    Men and women over 18 years of age with renal failure renal failure stages 3b/4/5, renal transplantation or dialysis and an untreated gout attack

    phase 3 small molecule active

    1 trial

  7. CPI-006 2 mg/kg + SOC

    Corvus Pharmaceuticals

    Covid-19

    phase 3 small molecule terminated

    1 trial

  8. CPT Dermatophagoides pteronyssinus LETI 100 HEP/ml, Formodual 100/6 microgramos/pulsación Solución para inhalación en envase a presión, Montelukast Teva 10 mg comprimidos recubiertos con película EFG, Budesonida Aldo-Unión- 200 microgramos/pulsación suspensión para inhalación en envase a presión., Salbutamol Aldo-Unión 100 microgramos/dosis suspensión para inhalación en envase a presión, AVAMYS 27.5 micrograms/spray, nasal spray suspension, Formodual Nexthaler 200 microgramos/6 microgramos por inhalación po

    Pharma Mar S.A.

    Allergic rhinoconjunctivitis to Dermatophagoides pteronyssinus and Dermatophagoides farinae

    phase 3 small molecule active

    1 trial

  9. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    High Risk Acute Myeloid Leukemia

    phase 3 small molecule completed

    1 trial

  10. CRT with triple site ventricular stimulation

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    phase 3 other completed

    1 trial

  11. CS1003, Placebo, LENVATINIB

    Pharma Mar S.A.

    Unresectable advanced hepatocellular carcinoma

    phase 3 small molecule active

    1 trial

  12. CTX001

    Vertex Pharmaceuticals (Ireland) Limited

    Beta-Thalassemia

    phase 3 mab active

    1 trial

  13. CYCLOPHOSPHAMIDE

    Pari Pharma GmbH

    The study will involve adult women and men from 16 French centers who have hematological malignancies and are candidates for haploidentical HSCT

    phase 3 small molecule active

    1 trial

  14. CYCLOPHOSPHAMIDE, Myocet liposomal 50 mg powder, dispersion and solvent for concentrate for dispersion for infusion., DOXORUBICIN, DOCETAXEL

    Cancer Prevention Pharma (Ireland) Limited

    oestrogen-receptor (ER)-positive HER2-negative breast carcinoma

    phase 3 small molecule active

    1 trial

  15. Cablivi 10 mg powder and solvent for solution for injection, Cablivi 10 mg powder and solvent for solution for injection, Cablivi 10 mg powder and solvent for solution for injection

    Sanofi Pharma Bristol-Myers Squibb

    Thrombotic Thrombocytopenic Purpura

    phase 3 small molecule active

    1 trial

  16. Cabozantinib

    Takeda Pharmaceuticals International AG

    Metastatic Prostate Cancer

    phase 3 small molecule active

    1 trial

  17. Calcium carbonate

    Arrowhead Pharmaceuticals Ireland Limited

    Uterine Contraction

    phase 3 small molecule completed

    1 trial

  18. Caldolor

    CUMBERLAND PHARMACEUTICALS INC

    Burns

    phase 3 small molecule completed

    1 trial

  19. Caldolor

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    phase 3 small molecule completed

    1 trial

  20. Caldolor

    CUMBERLAND PHARMACEUTICALS INC

    Fever

    phase 3 small molecule completed

    1 trial

  21. Calquence 100 mg hard capsules

    Pharma Mar S.A.

    Relapsed or Refractory Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    1 trial

  22. Calquence 100 mg hard capsules, CYCLOPHOSPHAMIDE, RITUXIMAB, DOXORUBICIN, Placebo, 100mg hard capsules; Identical to IMP apart from the active substance, VINCRISTINE, PREDNISONE

    Pharma Mar S.A.

    Diffuse large B-cell lymphoma

    phase 3 small molecule active

    1 trial

  23. Candesartan

    Takeda Pharmaceuticals International AG

    Heart Failure

    phase 3 small molecule completed

    1 trial

  24. Candesartan Cilexetil

    Takeda Pharmaceuticals International AG

    Stroke

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources